Evidence map›Paper›PMID 32250751›Full record

GuidelineJACC. Cardiovascular interventions2020

Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement.

Pinak B Shah, Frederick G P Welt, Ehtisham Mahmud, Alistair Phillips, Neal S Kleiman, Michael N Young, Matthew Sherwood, Wayne Batchelor, Dee Dee Wang, Laura Davidson and 7 more

Open access · greenAbstract readPractice Guideline
In one paragraph

Guideline in JACC. Cardiovascular interventions, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Article
  4. Changing haemodynamic status of patients referred for transcatheter aortic valve intervention during the COVID-19 pandemic.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2023
    Article
  5. Article
  6. Observational
  7. Review
  8. Review
  9. Article
  10. Transcatheter aortic valve implantation amid the COVID-19 pandemic: a nationwide analysis of the first COVID-19 wave in the Netherlands.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Finding sideline benefits-Of pandemics and same-day-discharge following rotational atherectomy.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2021
    Article
  16. Article
  17. Safety and Feasibility of Transcatheter Aortic Valve Replacement in COVID-19 Patients: A Case Series.Cardiovascular revascularization medicine : including molecular interventions · 2021
    Article
  18. Transcatheter Aortic Valve Implantation During COVID-19 Pandemic: The Device Also Matters.Cardiovascular revascularization medicine : including molecular interventions · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Pinak B ShahAmerican College of Cardiology Interventional Cardiology Section Leadership Council, Washington, DC; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: pbshah@partners.org.
Frederick G P WeltAmerican College of Cardiology Interventional Cardiology Section Leadership Council, Washington, DC; Cardiovascular Division, University of Utah Health, Salt Lake City, Utah.
Ehtisham MahmudSociety for Cardiovascular Angiography and Interventions, Washington, DC; Division of Cardiovascular Medicine, University of California-San Diego, San Diego, California.
Alistair PhillipsAmerican College of Cardiology Cardiac Surgery Team and Leadership Council, Washington, DC; The Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.
Neal S KleimanAmerican College of Cardiology Interventional Cardiology Section Leadership Council, Washington, DC; Cardiovascular Division, Houston Methodist Hospital, Houston, Texas.
Michael N YoungAmerican College of Cardiology Interventional Cardiology Section Leadership Council, Washington, DC; Cardiovascular Division, Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
Matthew SherwoodAmerican College of Cardiology Interventional Cardiology Section Leadership Council, Washington, DC; Division of Cardiology, Inova Heart and Vascular Institute, Fairfax, Virginia.
Wayne BatchelorAmerican College of Cardiology Interventional Cardiology Section Leadership Council, Washington, DC; Division of Cardiology, Inova Heart and Vascular Institute, Fairfax, Virginia.
Dee Dee WangHenry Ford Health System, Center for Structural Heart Disease, Wayne State University School of Medicine, Detroit, Michigan.
Laura DavidsonAmerican College of Cardiology Interventional Cardiology Section Leadership Council, Washington, DC; Bluhm Cardiovascular Institute, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Janet WymanAmerican College of Cardiology Interventional Cardiology Section Leadership Council, Washington, DC; Henry Ford Health System, Center for Structural Heart Disease, Wayne State University School of Medicine, Detroit, Michigan.
Sabeeda KadavathAmerican College of Cardiology Interventional Cardiology Section Leadership Council, Washington, DC; Department of Cardiovascular Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Molly SzerlipSociety for Cardiovascular Angiography and Interventions, Washington, DC; Baylor Scott and White, The Heart Hospital Plano, Plano, Texas.
James HermillerSociety for Cardiovascular Angiography and Interventions, Washington, DC; Ascension Medical Group, Indianapolis, Indiana.
David FullertonAmerican College of Cardiology Cardiac Surgery Team and Leadership Council, Washington, DC; Division of Cardiothoracic Surgery, University of Colorado School of Medicine, Denver, Colorado.
Saif AnwaruddinAmerican College of Cardiology Interventional Cardiology Section Leadership Council, Washington, DC; Cardiovascular Division, The Hospital of the University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.
American College of Cardiology and the Society for Cardiovascular Angiography and Interventions
American College of Cardiology · USBaylor Medical Center at Garland · USHenry Ford Health System · USSt. Vincent Hospital · USUniversity of California San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease-2019 (COVID-19) pandemic has strained health care resources around the world, causing many institutions to curtail or stop elective procedures. This has resulted in an inability to care for patients with valvular and structural heart disease in a timely fashion, potentially placing these patients at increased risk for adverse cardiovascular complications, including CHF and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic against the risk of delaying a needed procedure. In this document, the authors suggest guidelines for how to triage patients in need of structural heart disease interventions and provide a framework for how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, the authors address the triage of patients in need of transcatheter aortic valve replacement and percutaneous mitral valve repair. The authors also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.

Indexed as

BetacoronavirusCardiovascular Surgical ProceduresPatient SelectionTriageAmbulatory Surgical ProceduresCoronavirus InfectionsCOVID-19Heart DiseasesHumansPandemicsPneumonia, ViralReferral and ConsultationSARS-CoV-2COVID-19MitraClipstructural heart diseaseTAVR

Identifiers

PMID32250751
PMCPMC7270905
OpenAlexW3014835562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.